Literature DB >> 3134385

Simultaneous determination of nitroglycerin and its dinitrate metabolites by capillary gas chromatography with electron-capture detection.

F W Lee1, N Watari, J Rigod, L Z Benet.   

Abstract

A sensitive gas chromatographic-electron-capture detection method for the simultaneous determination of the antianginal drug nitroglycerin (GTN) and its dinitrate metabolites (1,2-GDN and 1,3-GDN) was developed. Human plasma samples (1 ml) spiked with 2,6-dinitrotoluene as the internal standard were extracted once with 10 ml of a methylene chloride-pentane mixture (3:7, v/v). Using this solvent system, less contaminants are extracted into the organic phase from plasma, resulting in cleaner chromatograms and prolonged column life. A break point was observed on the standard curves of GTN and GDNs. The two linear regions for the detectable concentrations of GTN are 0.025-0.3 and 0.3-3 ng/ml and for 1,2-GDN and 1,3-GDN they are 0.1-1 and 1-10 ng/ml. The limits of detection by this method for GTN, 1,2-GDN and 1,3-GDN in plasma are 0.025, 0.1 and 0.1 ng/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134385     DOI: 10.1016/s0378-4347(00)81954-4

Source DB:  PubMed          Journal:  J Chromatogr


  9 in total

1.  Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.

Authors:  N Higo; R S Hinz; D T Lau; L Z Benet; R H Guy
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

2.  Variable glyceryl dinitrate formation following infusions of glyceryl trinitrate at different vascular sites in the rat.

Authors:  E Nakashima; D T Lau; L Z Benet
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

Review 3.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

4.  Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations.

Authors:  R L Williams; K M Thakker; V John; E T Lin; W Liang-Gee; L Z Benet
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

5.  Nitroglycerin dinitrate metabolites do not affect the pharmacokinetics and pharmacodynamics of nitroglycerin in the dog: a preliminary report.

Authors:  F W Lee; J Hu; C H Metzler; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1993-04

6.  Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro.

Authors:  T Kikkoji; M Gumbleton; N Higo; R H Guy; L Z Benet
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

7.  Simultaneous pharmacodynamic modeling of the non-steady-state effects of three oral doses of 1,3-glyceryl dinitrate upon blood pressure in healthy volunteers.

Authors:  M Gumbleton; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1993-10

8.  Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure.

Authors:  J A Bauer; H L Fung
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

9.  Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.

Authors:  F W Lee; T Salmonson; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1993-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.